Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Skorpios Trust files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Adrian R. Krainer - $3.90M in STOK purchases and sales in the last 12 months
- Barry Ticho - $1.88M in STOK purchases and sales in the last 12 months
- Jonathan Allan - $1.20M in STOK purchases and sales in the last 12 months
- Edward M. Md Kaye - $934K in STOK purchases and sales in the last 12 months
- Arthur Tzianabos - $174K in STOK purchases and sales in the last 12 months
- Thomas Leggett - $147K in STOK purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is Skorpios Trust?
Skorpios Trust is a trust, tracked as 10% Owner of Stoke Therapeutics, Inc. (STOK). InsiderAlpha holds 1 primary Form 4 filing for it, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Skorpios Trust last file a Form 4?
The only primary Form 4 on record is dated 27 December 2024.
Has Skorpios Trust been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($23.00M) across all tracked filings.
